M-A | Bioresorbable vascular scaffolds are inferior compared to conventional drug-eluting stents across time.
10 Nov, 2022 | 13:57h | UTC
Commentary on Twitter
Bioresorbable vascular scaffolds #BVS vs. conventional drug-eluting stents #DES across time:
A #metaanalysis of RCTs@banerjeep https://t.co/XyDVI7XNMi pic.twitter.com/AjEPC6Zv3E— Open Heart (@Open_HeartBMJ) October 27, 2022